There’s no wrong way to experience #KCRS26, just the way that works best for you. However you attend, you'll be part of the community working to accelerate progress in #KidneyCancer research. Register today: https://bit.ly/KCRS26Registration #AcceleratingCures
Cris Bergerot, PhD
@crisbergerot.bsky.social
Advancing oncology care through research, innovation, and multidisciplinary collaboration. Passionate about patient-centered solutions, PROs, HRQOL, and evidence-based practices, w a focus on #GUOnc, #GeriOnc & #PallOnc #ASCO25 FCOI: http://bit.ly/344gKxq
People with SMI face inequities in cancer care and survival Equitable oncology requires integrated psychiatric care and system-level change @cacancerjournal.bsky.social #McFarland @kellyirwin25.bsky.social acsjournals.onlinelibrary.wiley.com/doi/10.3322/...
As a rural practitioner I thank Prof Anna Ugalde for the work she + team @deakinuniversity.bsky.social does on supportive care & bringing equitable cancer outcomes in rural and remote communities closer to reality. #MASCC26 @cancercaremascc.bsky.social @markbutlermp.bsky.social @theracp.bsky.social
Excited to be selected as a social media ambassador for #MASCC26! Looking forward to sharing the latest research in supportive care alongside my amazing colleagues from across the globe! Follow along! @cancercaremascc.bsky.social
👥 Registration opens at 3pm today for @cancercaremascc.bsky.social #MASCC26! 🩺 Can’t wait to see and learn alongside my colleagues & present on survivorship with @michael-jefford.bsky.social & #DrLarissaNekhlyudov! 🇦🇺 See you soon!
Loneliness interventions: Categories, examples, and end-of-life modifications. #geriatrics https://agsjournals.onlinelibrary.wiley.com/doi/10.1111/jgs.70542
Our new position statement outlines ways to expand eligibility, increase funding & expand community access for pediatric oncology clinical trials. Learn more: https://bit.ly/4v1q7J7 #ASCOAdvocacy
Less than 2 weeks to go! Webinar: High Risk of Fear of Cancer Recurrence June 15, 2026, 1 to 2 p.m. EDT Live Webcast FEATURING: 1. Lauren Rudy 2. Prof. Dr. Marije van der Lee 3. Dr. Sophie Lebel For more information and to register ipos-society.org/event-6683185
🎙 It's the final daily episode of #ASCO26! Dr. Monty Pal of @cityofhope.bsky.social provides his Top Takeaways on key Day 5 abstracts, available now on the #ASCODailyNews Podcast: https://bit.ly/3Rv9wPj
Heading home from #ASCO26 today! Put two dates for @ascocancer.bsky.social Quality Care Symposium on your calendar: 🚨Abstracts are due in 2 weeks 6/16/2026 📆 #ASCOQLTY26 is Friday-Saturday 10/16-17/2026 See you in Boston! www.asco.org/quality
Don’t miss our joint session w/ American Society of Preventive Oncology chaired by Dr Kimmie Ng of @danafarber.bsky.social & Dr Irene Su w panelists @crisbergerot.bsky.social & Dr. Tara Henderson of @luriechildrens.bsky.social on rising incidence of young adults w cancer. https://bit.ly/4e4idHY
The final study presented at #ASCO26 Plenary: RASolute-302 results show daraxonrasib meeting all primary and key secondary endpoints, demonstrating significant and clinically meaningful improvements in OS, PFS, and ORR in metastatic #PDAC: https://bit.ly/49r62n1 #ASCODailyNews
ASCO26 Must-Read Abstracts - Cristiane D Bergerot @crisbergerot.bsky.social oncodaily.com/voices/crist... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
Cristiane D Bergerot: ASCO26 Must-Read Abstracts - OncoDaily
Cristiane D Bergerot: ASCO26 Must-Read Abstracts / Abhishek Tripathi, Alex Chehrazi-Raffle, Alex Dos Santos, Alexander Chehrazi-Raffle, Ali Moradi, Alicia
oncodaily.com
1 week left to go. Will you be there? #pallonc #supponc #ASCO26 @crisbergerot.bsky.social @realbowtiedoc.bsky.social @tingtingzhang.bsky.social @fionnualacrowley.bsky.social @ericroeland.bsky.social @mazietsangmd.bsky.social @ascocancer.bsky.social @darcyburbage.bsky.social @rsedhom.bsky.social
Join us for our **Live Meeting** @ascocancer.bsky.social on Saturday May 30th 4:30-6p CST Room E253cd #ASCO26 @realbowtiedoc.bsky.social @darcyburbage.bsky.social @crisbergerot.bsky.social @tingtingzhang.bsky.social @fionnualacrowley.bsky.social @ericroeland.bsky.social
Join us for our **Live Meeting** @ascocancer.bsky.social on Saturday May 30th 4:30-6p CST Room E253cd #ASCO26 @realbowtiedoc.bsky.social @darcyburbage.bsky.social @crisbergerot.bsky.social @tingtingzhang.bsky.social @fionnualacrowley.bsky.social @ericroeland.bsky.social
Powerful article published earlier this month in the @nytimes.com “Under 40 and Diagnosed With Cancer” #AYA #oncologynursing @fumikochino.bsky.social @ekdrake.bsky.social @scottcapozza.bsky.social @pallonccop.bsky.social www.nytimes.com/interactive/...
Under 40 and Diagnosed With Cancer
Hundreds of New York Times readers shared their experiences with early-onset cancers. Here are seven of their stories.
nytimes.com
IKCC and the Global Cancer Coalitions Network are convening at IARC-WHO in Lyon, France for the GCCN Annual Meeting 2026. Representatives from global patient association networks are collaborating to address the challenges faced by patient organisations and to establish shared goals for 2030.
Apply by May 1: All #NCTN group members are eligible! @swog.org Virtual Grant Writing Workshop #SWOGonc conta.cc/3Qqnm4M
Webinar: Expert Session FORWard Interest Group Featuring Ben Smith (Australia) — May 18, 2026 Dr. Ben Smith has a particular interest in fear of cancer recurrence, digital health interventions and underserved populations impacted by cancer. Read more ipos-society.org/event-6673842
World Kidney Cancer Day is just around the corner—less than two months to go! 💙 Mark your calendars for 18 June 2026, and join us as we shine a light on this year’s important theme: Kidney Cancer and Emotional Wellbeing. Find out more: ikcc.org/world-kidney... #WorldKidneyCancerDay #WKCD
Managing advanced RCC after adjuvant immunotherapy In this roundtable discussion, experts explore treatment strategies for patients with disease progression following adjuvant pembrolizumab. 🎥 : https://ow.ly/o2FW50YLe9Q
Abstract titles for #ASCO26 are now available! Get a first look at the science that will be presented and be a part of the conversation. Browse the titles and start planning your experience: https://bit.ly/4cecv6w If you haven’t yet registered, early reg ends tomorrow!
Updated NCCN guidance recommends starting breast cancer screening at age 35 for women identified as high-risk through AI models or other validated risk assessment tools. ➡️ This signals a broader move toward data-driven, individualized screening pathways. https://ow.ly/WFjY50YLecm
NCCN Guidelines Update Recommends Breast Cancer Screening at Age 35 for High-Risk Women Identified by AI
ow.ly
Elevate the quality, safety & efficiency of cancer care delivery—submit your research to #ASCOQLTY26. By presenting findings, you’re shaping a vibrant community of professionals dedicated to advancing patient care. Prepare your submission: https://bit.ly/4cF0WUW
Cancer risk isn’t just about age. A study of 450K people shows lifetime risk varies by up to 2x between individuals. Age-only screening misses high-risk patients and overtests low-risk ones. The future? Personalized, risk-based screening. Read the full article: https://bit.ly/4dYankA
Our FINAL #webinar for the year 😢 before #ASCO26. Join us for the amazing #DrDale and @mycarg.bsky.social cross over #pallonc #supponc #gerionc
We are so excited for our April meeting in collaboration with @mycarg.bsky.social and #GeriOncCoP with guest speaker #DrDale Please DM for the link or to be added to the mailing list. @crisbergerot.bsky.social @realbowtiedoc.bsky.social @tingtingzhang.bsky.social @fionnualacrowley.bsky.social
🎉Thank you to our dedicated volunteers! Together we connected with lawmakers & advocated for cancer care and research priorities during the 2026 #ASCOAdvocacySummit and Week of Action. Learn more: https://bit.ly/4vOEbX8
We are so excited for our April meeting in collaboration with @mycarg.bsky.social and #GeriOncCoP with guest speaker #DrDale Please DM for the link or to be added to the mailing list. @crisbergerot.bsky.social @realbowtiedoc.bsky.social @tingtingzhang.bsky.social @fionnualacrowley.bsky.social
Very happy to be here at #AACR26 with our outstanding @theaacr.bsky.social AACR Scientist↔️Survivor Program partner advocates. 47 patient advocates on site from around the world, selected from over 400 (!) applications.